ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500257 announcements Lupin Ltd. announcements and dividends declared BSE

Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257

Lupin Ltd. 500257 listed on BSE and deals in

Announcements and dividends declared by Lupin Ltd. 500257

Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050
Lupin shares fell after Citi downgraded the stock to ‘Sell’ and cut its target price to Rs 2,050. The brokerage expects weaker US base-business sales, margin pressure and limited benefits from new products. Citi also reduced FY27 EPS estimates by 14%. Lupi
Announcement as on 27 August 2026

Lupin allots 30,967 equity shares under ESOP
In view of the above, the issued and paid-up share capital of the Company has increased to Rs 91,45,31,722 consisting of 45,72,65,861 equity shares of Rs 2/- each.
Announcement as on 25 August 2026

Lupin arm to commercialise YUVEZZI eye drop across key European markets
Lupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-up vision in adults. VISUfarma will undertake regulatory activities and commercialization of the eye drop. The agreeme
Announcement as on 20 August 2026

Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepiness
Pharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treating excessive daytime sleepiness in patients. The US health regulator approved strengths of 4.45 mg and 17.8 mg. Lup
Announcement as on 17 August 2026

Lupin receives USFDA approval for Sodium Zirconium Cyclosilicate for Oral Suspension
Lupin announced that it has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sodium Zirconium Cyclosilicate for Oral Suspension, 5 g/packet and 10 g/packet.
Announcement as on 10 August 2026

Announcements by Lupin Ltd. first page | Next page | Prev page |

500257 Lupin Ltd. current price & indicator signals

Moving Averages for Lupin Ltd.

  • 5Day Average: 1977.41
  • 12Day Average: 1960.05
  • 20Day Average: 1985.62
  • 50Day Average: 2083.77
  • 100Day Average: 2228.55
  • 150Day Average: 2253.89
  • 200Day Average: 2243.74

500257 Indicators & signals

Indicator MACD (12,26,9)

1978, 2012.69, -46.54
Indicator MACD is in negative zone

Indicator ADX (14)

0.35, 21.15, 21.01
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 2009.00 1974.05 to 2020.40 0.55% 0.66 times
29 Thu Oct 2026 1998.00 1964.00 to 1999.75 1.37% 0.74 times
28 Wed Oct 2026 1971.00 1935.00 to 1974.00 0.61% 0.45 times
27 Tue Oct 2026 1959.05 1942.40 to 1965.00 0.46% 2.07 times
26 Mon Oct 2026 1950.00 1915.00 to 1950.00 1.3% 0.36 times
23 Fri Oct 2026 1925.00 1893.25 to 1928.60 -0.16% 2.18 times
22 Thu Oct 2026 1928.00 1897.25 to 1944.70 -1.48% 0.4 times
21 Wed Oct 2026 1957.00 1929.60 to 1959.30 0.17% 1.42 times
19 Mon Oct 2026 1953.75 1931.40 to 1969.90 -0.1% 0.19 times
16 Fri Oct 2026 1955.80 1948.00 to 1988.75 -0.17% 1.01 times
15 Thu Oct 2026 1959.20 1942.20 to 1990.00 0.23% 1.19 times
14 Wed Oct 2026 1954.80 1926.00 to 1954.90 -0.27% 2.13 times

Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500257 announcements Lupin Ltd. announcements and dividends declared BSE

 

Back to top